Helicos Secures Bridge Loan, Abandons Plans for CLIA Lab as Cash Position Weakens, Revenues Fall
November 30, 2010
Helicos Secures Bridge Loan, Abandons Plans for CLIA Lab as Cash Position Weakens, Revenues Fall
With a cash position of $1.9 million as of Nov. 10, Helicos has reduced its headcount and has dropped plans to develop its own CLIA-certified genetic testing lab.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- USPTO Grants Life Tech's Request to Reexamine Helicos Patent; Helicos Says IP Covers Ion Torrent Tech
September 13, 2011 / In Sequence - Helicos Appoints New CEO; Launches Technology Licensing Program
October 19, 2010 / In Sequence - Helicos to Install Second Sequencer at Stanford; Sells Instrument to Private Research Institute
February 9, 2010 / In Sequence - Helicos BioSciences Sells Sequencer to Dutch Medical Center
November 17, 2009 / In Sequence - Helicos Reports $1.1M in Q3 Revenue; Rules Out Company Sale for Now as Prospects Improve
November 10, 2009 / In Sequence